Downstream Processing Featured Articles
-
Nanotherapeutics Selects GE Healthcare Life Sciences Technologies For Advanced Development And Manufacturing Center
1/22/2014
GE Healthcare recently announced that biopharmaceutical company Nanotherapeutics, Inc. has selected GE Healthcare Life Sciences' FlexFactory biomanufacturing platform to perform a central role in its Advanced Development and Manufacturing (NANO-ADM) Center at Alachua, Florida, USA.
-
Biopharma Vendor Satisfaction: Are Suppliers Doing What’s Best For The Industry?
12/7/2011
Biopharmaceutical manufacturers are demanding more from their vendors’ R&D teams. This year, we found in our annual study that end users are more aggressively asking their suppliers for solutions to their biomanufacturing problems. By Eric Langer, president and managing partner, BioPlan Associates, Inc.
-
The Benefits Of Genderless Sterile Connectors For Single-Use Applications
Genderless connections are those in which the connector halves are identical in design, thus eliminating the need for different male and female halves to make the connection.
-
Getting The Most For Your Bioanalytical Testing Buck
9/28/2012
When evaluating your analytical testing operation or even selecting a CRO to do your analytical testing, there are several things to consider improving your operations.
-
TAP Collaborates With CCRM On Process Optimisation Project For Cell Therapies
12/3/2012
TAP Biosystems, a leading supplier of innovative cell culture systems and consumables for life science applications, has joined the Centre for Commercialization of Regenerative Medicine’s (CCRM) industry consortium to translate laboratory cell culture conditions into optimized processes and media for commercial production of cellular therapies.
-
Theratechnologies Secures US Patent For Its Novel Peptide TH1173
1/29/2013
Theratechnologies Inc. (TSX:TH)(NASDAQ:THER) today reported that the US Patent and Trademark Office (USPTO) has granted a patent (US Patent No. 8,361,964) for its second generation growth-hormone releasing factor (GRF) peptide, TH1173, providing for patent protection beyond 2030.
-
GE Healthcare Launches ÄKTA™ Pure, A New Modular Chromatography System For Protein Purification
8/24/2012
GE Healthcare, the healthcare business of GE announced recently the launch of ÄKTA™ pure, a chromatography system for flexible, reliable and intuitive purification of proteins.
-
NIST Study Suggests Carbon Nanotubes May Protect DNA From Oxidation
11/14/2012
Researchers at the National Institute of Standards and Technology (NIST) have provided evidence in the laboratory that single-wall carbon nanotubes (SWCNTs) may help protect DNA molecules from damage by oxidation.
-
CDER-ETP: A Resource For Innovative Biopharma Firms
1/15/2020
The FDA’s Center for Drug Evaluation and Research’s Emerging Technology Program (CDER-ETP), is yet another step toward removing slow-moving bureaucracy and red tape that stands in the way of innovative new technologies that drive drug development.
-
Change On The Horizon For Biomanufacturing
1/26/2012
A leading indicator as to where the global bio industry is headed, geographically, is where its global vendors are setting up shop. In our 8th Annual Report and Survey of Biopharmaceutical Manufacturing, along with 352 biomanufacturers, we also surveyed 186 suppliers to the industry. By Eric Langer, president and managing partner, BioPlan Associates, Inc.